Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02113514 · ClinicalTrials.gov registry record
Community Awareness, Resources and Education (CARE I): Project 3
A clinical trial of Cervical Abnormality, sponsored by Ohio State University Comprehensive Cancer Center.
- Completed
- Registry status
- 2,394
- Enrollment target
- 2
- Study locations
NCT02113514 is a study of Cervical Abnormality that has completed, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 2,394 participants. The trial reports 2 study locations across 2 states.
The verdict
NCT02113514, a study of Cervical Abnormality, has completed, sponsored by Ohio State University Comprehensive Cancer Center.
- COMPLETED
- Registry status
- 2,394 participants
- Enrollment target
- 2
- Study locations
Study Summary
Community Awareness, Resources and Education (CARE) Project - Project 3 will determine if Appalachian women have unique risk factors for an abnormal Pap smear that might contribute to the increased risk of cervical abnormalities, specifically cancer, in their communities.
Conditions Studied
Study Locations (2)
Michigan
- University of Michigan - Ann Arbor
Ohio
- The Ohio State University - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,394 participants |
| Start Date | 2005-05 |
| Est. Completion | 2009-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02113514
The ClinicalTrials.gov registry entry for NCT02113514 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2,394 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University Comprehensive Cancer Center, which has 341 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cervical Abnormality appearing as the primary indexed condition, and to 0 interventions.
NCT02113514 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Michigan, Ohio.
Frequently Asked Questions
What is clinical trial NCT02113514 about?
NCT02113514 is a clinical study titled "Community Awareness, Resources and Education (CARE I): Project 3". Community Awareness, Resources and Education (CARE) Project - Project 3 will determine if Appalachian women have unique risk factors for an abnormal Pap smear that might contribute to the increased risk of cervical abnormalities, specifically cancer, in their communities.
What is the current status of trial NCT02113514?
This trial is currently completed. The enrollment target is 2,394 participants. The study started on 2005-05. Estimated completion is 2009-01.
What conditions does trial NCT02113514 study?
This clinical trial studies the following conditions: Cervical Abnormality.
Who is sponsoring clinical trial NCT02113514?
This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02113514 being conducted?
This trial has 2 study locations across Michigan, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.